Vamil Divan, Guggenheim Securities biopharmaceutical analyst, joins ‘Energy Lunch’ to debate Merck’s troubles in China.
02:46
an hour in the past
Vamil Divan, Guggenheim Securities biopharmaceutical analyst, joins ‘Energy Lunch’ to debate Merck’s troubles in China.
02:46
an hour in the past